Our team has a wealth of experience and expertise in the development of protein/peptide therapeutics and an in-depth understanding of the needs of the pharmaceutical industry when it comes to the development and manufacture of novel, effective and safe biologics. In addition, with our business acumen and experience of forming strategic alliances we are working to build effective partnerships to deliver biologics solutions:
Alan Lamb | Non-Exec Director
Alan has broad experience as director, manager and entrepreneur in technology businesses from early stage through to being part of a large public company. He led the MBO of Computer Security International from Advent which was acquired by Racal Electronics where he was CEO of Racal IT Security. In the last 15 years he has focused on developing spin-out companies from UK universities as a mentor, chairman and non-executive director. He is chairman of Promethean Particles, a supplier of specialist nano-particles, and of Gyrometric Systems who provide condition monitoring for offshore wind turbines. He was an independent director of Kings Arms Yard VCT plc for 10 years and is a nonexecutive director of Resilient Networks plc. He holds a degree in Engineering Science and an MBA.